1. A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease. Issue 1 (8th June 2020) Authors: Macaluso, Fabio Salvatore; Ventimiglia, Marco; Fries, Walter; Viola, Anna; Sitibondo, Aldo; Cappello, Maria; Scrivo, Barbara; Busacca, Anita; Privitera, Antonino Carlo; Camilleri, Salvatore; Garufi, Serena; Di Mitri, Roberto; Mocciaro, Filippo; Belluardo, Nunzio; Giangreco, Emiliano; Bertolami, C... Other Names: Ang Tiing–Leong guestEditor. Journal: Journal of gastroenterology and hepatology Issue: Volume 36:Issue 1(2021) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis. Issue 12 (December 2020) Authors: Macaluso, Fabio Salvatore; Ventimiglia, Marco; Fries, Walter; Viola, Anna; Cappello, Maria; Scrivo, Barbara; Magnano, Antonio; Pluchino, Dario; Camilleri, Salvatore; Garufi, Serena; Mitri, Roberto Di; Mocciaro, Filippo; Magrì, Giovanni; Ferracane, Concetta; Citrano, Michele; Graziano, Francesco; ... Journal: Digestive and liver disease Issue: Volume 52:Issue 12(2020) Page Start: 1461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients With Crohn's Disease: Real-Life Data From the Sicilian Network for Inflammatory Bowel Disease. (6th October 2018) Authors: Macaluso, Fabio Salvatore; Fries, Walter; Privitera, Antonio Carlo; Cappello, Maria; Siringo, Sebastiano; Inserra, Gaetano; Magnano, Antonio; Di Mitri, Roberto; Mocciaro, Filippo; Belluardo, Nunzio; Scarpulla, Giuseppe; Magrì, Giovanni; Trovatello, Antonino; Carroccio, Antonio; Genova, Salvatore;... Journal: Journal of Crohn's and colitis Issue: Volume 13:Number 2(2019) Page Start: 209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study. Issue 9 (November 2020) Authors: Macaluso, Fabio Salvatore; Fries, Walter; Renna, Sara; Viola, Anna; Muscianisi, Marco; Cappello, Maria; Guida, Laura; Siringo, Sebastiano; Camilleri, Salvatore; Garufi, Serena; Privitera, Antonino Carlo; Belluardo, Nunzio; Giangreco, Emiliano; Bertolami, Carmelo; Vassallo, Roberto; Rizzuto, Giuli... Journal: United European Gastroenterology journal Issue: Volume 8:Issue 9(2020) Page Start: 1045 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effectiveness and safety of vedolizumab in biologically naïve patients: A real‐world multi‐centre study. Issue 9 (1st November 2020) Authors: Macaluso, Fabio Salvatore; Fries, Walter; Renna, Sara; Viola, Anna; Muscianisi, Marco; Cappello, Maria; Guida, Laura; Siringo, Sebastiano; Camilleri, Salvatore; Garufi, Serena; Privitera, Antonino Carlo; Belluardo, Nunzio; Giangreco, Emiliano; Bertolami, Carmelo; Vassallo, Roberto; Rizzuto, Giuli... Journal: United European Gastroenterology journal Issue: Volume 8:Issue 9(2020) Page Start: 1045 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SPOSAB ABP 501 - A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501. (21st January 2021) Authors: Macaluso, Fabio Salvatore; Cappello, Maria; Busacca, Anita; Fries, Walter; Viola, Anna; Costantino, Giuseppe; Magnano, Antonio; Vinci, Elisa; Ferracane, Concetta; Privitera, Antonino Carlo; Piccillo, Giovita; Belluardo, Nunzio; Giangreco, Emiliano; Romano, Claudio; Citrano, Michele; Graziano, Fra... Journal: Inflammatory bowel diseases Issue: Volume 27(2021)Supplement 1 Page Start: S59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SPOSAB ABP 501: A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501. Issue 11 (3rd July 2021) Authors: Macaluso, Fabio Salvatore; Cappello, Maria; Busacca, Anita; Fries, Walter; Viola, Anna; Costantino, Giuseppe; Magnano, Antonio; Vinci, Elisa; Ferracane, Concetta; Privitera, Antonino Carlo; Piccillo, Giovita; Belluardo, Nunzio; Giangreco, Emiliano; Romano, Claudio; Citrano, Michele; Graziano, Fra... Journal: Journal of gastroenterology and hepatology Issue: Volume 36:Issue 11(2021) Page Start: 3041 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches. Issue 2 (19th January 2021) Authors: Macaluso, Fabio Salvatore; Fries, Walter; Viola, Anna; Centritto, Andrea; Cappello, Maria; Giuffrida, Enrica; Privitera, Antonino Carlo; Piccillo, Giovita; Magnano, Antonio; Vinci, Elisa; Vassallo, Roberto; Trovatello, Antonino; Belluardo, Nunzio; Giangreco, Emiliano; Camilleri, Salvatore; Garufi... Journal: Inflammatory bowel diseases Issue: Volume 27:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches. Issue 2 (21st February 2020) Authors: Macaluso, Fabio Salvatore; Fries, Walter; Viola, Anna; Centritto, Andrea; Cappello, Maria; Giuffrida, Enrica; Privitera, Antonino Carlo; Piccillo, Giovita; Magnano, Antonio; Vinci, Elisa; Vassallo, Roberto; Trovatello, Antonino; Belluardo, Nunzio; Giangreco, Emiliano; Camilleri, Salvatore; Garufi... Journal: Inflammatory bowel diseases Issue: Volume 27:Issue 2(2021) Page Start: 182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗